Disclosures for "Breaking Barriers in Early Alzheimer's Disease Diagnosis: The Power of the In Vitro Diagnostic Elecsys pT181p Immunoassay in a Population Reflective of Real-world Clinical Practice"
-
Dr. Hortsch has received personal compensation for serving as an employee of Roche Diagnostics GmbH.
-
Mr. Caley has nothing to disclose.
-
Dr. Menzel has nothing to disclose.
-
Prof. Rowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Prof. Rowe has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prothena. Prof. Rowe has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Australia. Prof. Rowe has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Australia. Prof. Rowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Prof. Rowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Rowe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novo Nordisk. Prof. Rowe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Diagnostics. Prof. Rowe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson and Johnson. The institution of Prof. Rowe has received research support from Enigma. The institution of Prof. Rowe has received research support from Australian Dementia Network Ltd. The institution of Prof. Rowe has received research support from National Health and Medical Research Council. The institution of Prof. Rowe has received research support from Florey Institute of Neuroscience.
-
Dr. Rapp has nothing to disclose.
-
Dr. Aarsland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics.
-
Dr. Burke has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Burke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Burke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. An immediate family member of Dr. Burke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly.
-
Dr. Quijano Rubio has received personal compensation for serving as an employee of Roche Diagnostics International.